Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention Amany F. ElbehairyKatherine A. WebbDenis E. O’Donnell Current Opinion 09 November 2013 Pages: 1991 - 2001
Critical Appraisal of Ramucirumab (IMC-1121B) for Cancer Treatment: From Benchside to Clinical Use Giuseppe AprileMarta BonottoFrancesco Giuliani Leading Article 26 November 2013 Pages: 2003 - 2015
Promoting Remyelination in Multiple Sclerosis—Recent Advances E. Jolanda MünzelAnna Williams Review Article Open access 16 November 2013 Pages: 2017 - 2029
Crizotinib: A Review of Its Use in the Treatment of Anaplastic Lymphoma Kinase-Positive, Advanced Non-Small Cell Lung Cancer James E. Frampton Adis Drug Evaluation 28 November 2013 Pages: 2031 - 2051
Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome Gillian M. Keating Adis Drug Evaluation 19 November 2013 Pages: 2053 - 2066
Modified-Release Prednisone: in Patients with Rheumatoid Arthritis Sheridan HennessLily P. H. Yang Adis Drug Evaluation 19 November 2013 Pages: 2067 - 2076
Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer Sheridan M. Hoy Adis Drug Evaluation 23 November 2013 Pages: 2077 - 2091
Simeprevir: First Global Approval Asha VaidyaCaroline M. Perry R&D Insight Report 30 November 2013 Pages: 2093 - 2106